New Treatment for Peritoneal Cancer - IHH Healthcare
  • Join our community
  • IHH@LinkedIn
  • IHH@Youtube
  • IHH@Facebook
New Treatment for Peritoneal Cancer
19 Nov 2021

Gleneagles Hospital Hong Kong’s Peritoneal Malignancy Treatment Centre has introduced new intraperitoneal chemotherapy procedures, including Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC), to provide more effective treatment to patients with peritoneal cancer.

Dr Kenneth Tsang, Chief Executive Officer of Gleneagles Hospital Hong Kong, said, “In addition to our advanced radiotherapy facilities, we have also launched a centre dedicated to serving patients with peritoneal metastasis. Our experienced multidisciplinary medical team provides patients with comprehensive diagnostic services and personalised treatments.” The Centre is the first of its kind in Hong Kong catering to patients with peritoneal metastasis. Medical studies have found HIPEC to effectively improve the survival rate of patients with ovarian cancer, gastric cancer or colorectal cancer. The innovative PIPAC treatment is also known to relieve symptoms of peritoneal metastasis and reduce the side effects of chemotherapy, which helps improve the patient’s quality of life.

Topics:

Brands:

Related Stories

Parkway Shanghai Integrated Chinese and Western Medicine Health Management Services Thumbnail J

Parkway MediCentre Xintiandi Launches Integrated Chinese and Western Medicine Health Management Services

Themed "Echoes of the World, Pulse of China", Parkway MediCentre Xintiandi showcased the role of Traditional Chinese Medicine (TCM) through an integrated healthcare approach.

19 Nov 2021
Read More
Fortis Memorial Research Institute CoE for Myeloma & Lymphoma June 2026 Thumbnail

Fortis Memorial Research Institute (FMRI) Launches India's First Centre of Excellence for Myeloma and Lymphoma

Officiated on 11 June, the FMRI Centre of Excellence, brings a highly specialised, patient‑centred and research‑driven approach to managing blood cancers.

19 Nov 2021
Read More

Gleneagles Hospital Hong Kong Delivers Seamless Musculoskeletal Care

Gleneagles Hospital Hong Kong is strengthening musculoskeletal (MSK) care through closer collaboration, bringing together insurers and healthcare providers to support a more connected and patient-centred treatment journey.

19 Nov 2021
Read More

IHH Healthcare Singapore Recognised for Building Meaningful Employee Experiences

IHH Healthcare Singapore has been recognised with six wins at the 2026 Employee Experience Awards, a regional platform celebrating organisations that create meaningful, people-centric workplaces.
19 Nov 2021
Read More

Gleneagles Hospital Singapore showcased Enhanced Recovery After Surgery (ERAS®) programme at 12th ERAS® World Congress

Gleneagles Hospital Singapore is advancing surgical recovery through its adoption of the Enhanced Recovery After Surgery (ERAS®) programme, recognised for its early implementation in Singapore’s private healthcare sector.

19 Nov 2021
Read More

Expanding Care in Europe with Acibadem Rotterdam

Acibadem continues to expand its presence in Europe with the opening of Acibadem International Medical Center Rotterdam, located in the heart of the city within the iconic Unilever building.
19 Nov 2021
Read More
HOSPITALS
PRIMARY CARE
ANCILLARY SERVICES
  • Acibadem Labmed Logo
  • Agilus Diagnostics Logo
  • Parkway Laboratories
  • Parkway Radiology Logo
  • Parkway Rehab Logo
  • Premier Integrated Labs Logo
  • Premier Integrated Rehab Logo